All In MedTech

De Novo device

MISHA Knee System

Moximed, Inc. · Medial Knee Implanted Shock Absorber (QVV, Class II) · First FDA decision Apr 10, 2023, newest Apr 10, 2023Knee osteoarthritis

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

Breakthrough-designated

Device trials

4

Naming "MISHA"

MAUDE reports

18

Brand "MISHA", since 2015

PubMed studies

24

Mentioning "MISHA"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing MISHA Knee System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "MISHA", any status and sponsor, newest update first.

Open in Trial Radar
  • MoximedNot on our public-company list

    NCT03671213 · 81 participants · Start Sep 19, 2018 · Primary completion Jan 17, 2022

    Device: Calypso Knee System (Implantable Shock Absorber) · For: Osteoarthritis, Knee

    Sites: Columbia, Missouri; New York, New York; Columbus, Ohio · 5 sites in all

  • MoximedNot on our public-company list

    NCT03838978 · 81 participants · Start Feb 8, 2019 · Primary completion Jan 17, 2022

    Device: Calypso Knee System (Implantable Shock Absorber) · For: Osteoarthritis, Knee

    Sites: Ghent, Belgium; Lodz, Poland; Lublin, Poland · 5 sites in all

  • MoximedNot on our public-company list

    NCT06118892 · 120 participants (planned) · Start Nov 3, 2023 · Primary completion Jun 30, 2030

    Device: MISHA Knee System · For: Osteo Arthritis Knee

    Sites: Sonoma, California; Raleigh, North Carolina; Portland, Oregon · 4 sites in all

1 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "MISHA", and for the whole product code for context.

This brand

18 reports: 7 malfunction, 11 injury, 0 death

Whole product code QVV

18 reports: 7 malfunction, 11 injury, 0 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "MISHA"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.